Cart 0
Analytical Similarity Assessment in Biosimilar Product Development
Click to zoom

Share this book

Analytical Similarity Assessment in Biosimilar Product Development

Book Details

Format Paperback / Softback
ISBN-10 0367733838
ISBN-13 9780367733834
Publisher Taylor & Francis Ltd
Imprint Chapman & Hall/CRC
Country of Manufacture GB
Country of Publication GB
Publication Date Dec 18th, 2020
Print length 340 Pages
Weight 650 grams
Ksh 10,250.00
Werezi Extended Catalogue Delivery in 28 days

Delivery Location

Delivery fee: Select location

Delivery in 28 days

Secure
Quality
Fast
Focuses on analytical similarity assessment in biosimilar product development following the FDA’s recommended stepwise approach for obtaining totality-of-the-evidence for approval of biosimilar products. It will cover current issues, and recent development in analytical similarity assessment.

This book focuses on analytical similarity assessment in biosimilar product development following the FDA’s recommended stepwise approach for obtaining totality-of-the-evidence for approval of biosimilar products. It covers concepts such as the tiered approach for assessment of similarity of critical quality attributes in the manufacturing process of biosimilar products, models/methods like the statistical model for classification of critical quality attributes, equivalence tests for critical quality attributes in Tier 1 and the corresponding sample size requirements, current issues, and recent developments in analytical similarity assessment.






Get Analytical Similarity Assessment in Biosimilar Product Development by at the best price and quality guaranteed only at Werezi Africa's largest book ecommerce store. The book was published by Taylor & Francis Ltd and it has pages.

Mind, Body, & Spirit

Price

Ksh 10,250.00

Shopping Cart

Africa largest book store

Sub Total:
Ebooks

Digital Library
Coming Soon

Our digital collection is currently being curated to ensure the best possible reading experience on Werezi. We'll be launching our Ebooks platform shortly.